TIBER CREEK GROUP for EMD SERONO, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to corporate tax
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTEN HARPER | — |
| JEFFREY SHAPIRO | — |
Health Issues HCR
Issues relating to pharmaceutical pricing. Issues relating to drug development. S. 2543 - The Prescription Drug Price Reduction Act. H.R. 3 - Lower Drug Costs Now Act of 2019. H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ASHLI PALMER | — |
Trade (domestic/foreign) TRD
Issues related to supply chain management
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTEN HARPER | — |
| JEFFREY SHAPIRO | — |
Medicare/Medicaid MMM
Issues relating to Medicare Part D Price Reform. S. 2543 - The Prescription Drug Price Reduction Act. H.R. 3 - Lower Drug Costs Now Act of 2019. H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ASHLI PALMER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.